Hypophosphatemic Rickets: From Bench to Bedside

Component List:

  • Primer (9th edition) Chapter 25: FGF23 and the Regulation of Phosphorus Metabolism
  • Primer (9th edition) Chapter 88: Disorders of Phosphate Homeostasis
  • Webinar: X-Linked Hypophosphatemia: Natural History, Mechanistic Insights and Therapeutic Advances, Thomas O. Carpenter, M.D. (2019); Clinical Case Workshop on Treatment of Adult XLH
  • JBMR Article: Determination of FGF23 Levels for the Diagnosis of FGF23-Mediated Hypophosphatemia
  • JBMR Article: Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets
  • JBMR Article: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
  • JBMR Article: Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X-Linked Hypophosphatemia: Results From the Phase 3, Single-Arm International Trial

Key:

Complete
Failed
Available
Locked
Webinar: X-Linked Hypophosphatemia: Natural History, Mechanistic Insights and Therapeutic Advances
Open to view video.
Open to view video.
Clinical Case Workshop on Treatment of Adult XLH
Open to view video.
Open to view video.
JBMR Article: Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets
Open to download resource.
Open to download resource.
JBMR Article: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
Open to download resource.
Open to download resource.
JBMR Article: Bone Matrix Mineralization and Response to Burosumab in Adult Patients With X-Linked Hypophosphatemia: Results From the Phase 3, Single-Arm International Trial
Open to download resource.
Open to download resource.